ArticlePharmaceuticals (Basel, Switzerland)2026

Integrated AI-Driven Discovery of MAPK3 Inhibitors for Oral Inflammatory and Proliferative Diseases.

Muhammad Ishfaq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.